You have 9 free searches left this month | for more free features.

Condition

Candidemia (2)

Candida Infection (1)

Fungal Infection (1)

Invasive Candidiases (1)

Invasive Fungal Infections (1)

Overall Status

Completed (3)

Terminated (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (2)

Sponsor

Pfizer (3)

Amplyx Pharmaceuticals (1)

Collaborator

Intervention

apx001 (4)

apx001a (1)

itraconazole (1)

rifampin (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

apx001

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Invasive Fungal Infections Trial in Salt Lake City (APX001, APX001A)

Completed

Invasive Fungal Infections

APX001
APX001A

Salt Lake City, Utah

Pharmaceuticals Research Associates, Inc

Aug 4, 2022

Candidemia, Invasive Candidiases, Candida Infection Trial in Alberton, Johannesburg (APX001)

Terminated

Has Results

Candidemia
+2 more

APX001

Alberton, Gauteng, South Africa
+1 more

Dec 13, 2022

Fungal Infection Trial in Groningen (APX001, Itraconazole, Rifampin)

Completed

Fungal Infection

APX001
+2 more

Groningen, Netherlands

PRA-EDS

Oct 27, 2021

Candidemia Trial in Worldwide (APX001)

Completed

Has Results

Candidemia

APX001

Birmingham, Alabama
+19 more

Jul 14, 2021